Cytokinetics Grants Stock Options and RSUs Under Nasdaq Inducement Rule
Cytokinetics said it granted options covering 60,465 shares and 40,084 restricted stock units on October 15, 2026, under Nasdaq Listing Rule 5635(c)(4).
Cytokinetics said it granted options covering 60,465 shares and 40,084 restricted stock units on October 15, 2026, under Nasdaq Listing Rule 5635(c)(4).